Active Ingredient: ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
Proprietary Name: TRIUMEQ PD
Dosage Form; Route of Administration: TABLET, FOR SUSPENSION; ORAL
Strength: EQ 60MG BASE;EQ 5MG BASE;30MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N215413
Product Number: 001
Approval Date: Mar 30, 2022
Applicant Holder Full Name: VIIV HEALTHCARE CO
Marketing Status:
Prescription
Patent and Exclusivity Information
